Ethyl 2-(2-bromothiazol-5-yl)acetate, 95.0%, 250mg

3,4-DIHYDRO-6-[[4-[[[3-(METHYLSULFONYL)PHENYL]METHYL]AMINO]-5-(TRIFLUOROMETHYL)-PYRIMIDIN-2-YL]AMINO]-2(1H)-QUINOLINONE, 98%, 100mg

7-Bromo-2-methylquinazoline, 95.0%, 1g

tert-Butyl hexahydropyrrolo[3,2-b]pyrrole-1(2H)-carboxylate, 95.0%, 100mg

1,3-Di-p-tolylurea, 97%, 100mg

2-[(2,2-DIMETHYL-1-OXOPROPYL)AMINO]-4-PYRIDINECARBOXAMIDE, 95%, 1g

METHYL 4-BROMO-3-METHYLPICOLINATE, 95.0%, 500mg

6-Chloroquinazoline-2,4(1H,3H)-dione, 95.0%, 25g

1-(2-Chlorobenzyl)-1H-imidazole-2-carboxylic acid, 1g

Ethyl 6-chloro-2-oxohexanoate, 95.0%, 5g

1-adamantanecarboxylic acid, min. 99%, for synthesis, 25 g, plastic packaging.

2,3,4,5,6-Pentafluorostyrene, 99.0%, 25g

N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine, 98%, 5g